The lifetime prevalence of hypochondriasis is estimated to be around 1-5% (Abramowitz et al., 2007).
The aetiology of hypochondriasis is not well understood but is thought to involve both psychological and social factors.
Hypochondriasis is characterized by excessive and persistent fears of having a serious medical condition despite reassurances from healthcare professionals.
CBT is the preferred treatment for hypochondriasis, with or without medication. Education, reassurance, and monitoring of symptoms are also important components of treatment.
With appropriate treatment, most people with hypochondriasis can achieve significant symptom improvement and functional recovery.
Hypochondriasis | |
Prevalence | 1-5% |
Onset | Typically in early adulthood |
Gender | No significant gender differences |
Aetiology | Psychological and social factors |
Presentation | Excessive and persistent fears of having a serious medical condition |
Treatment | CBT, medication, education, reassurance, and monitoring |
Outcome | Significant symptom improvement and functional recovery |
References: